Main menu

Complex exon structure of CD19 and CD22 mRNA isoforms revealed by long-read Oxford Nanopore sequencing


B-cell acute lymphoblastic leukaemia (B-ALL) is the most common paediatric malignancy. CD19-CART immunotherapy has revolutionised its treatment.

CD19 alternative splicing was investigated with long-read nanopore direct cDNA and RNA sequencing, which obtained full-length profiles of CD19.

CD19 alternative splicing is associated with resistance to CAR T-cell immunotherapy.

Splicing of CD22, an alternative therapeutic target, was studied with nanopore sequencing; full-length transcripts revealed the complexity of CD22 isoforms.

Mukta summarised her talk stating that alternative splicing of target surface antigens, such as CD19 and CD22, generates many functional proteins which may impart resistance to immunotherapies such as CAR T-cells.

Authors: Mukta Asnani

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

ナノポア技術

ナノポアの最新ニュースを購読 リソースと発表文献 Nanopore Communityとは

Oxford Nanoporeについて

ニュース 会社沿革 持続可能性 経営陣 メディアリソース & お問い合わせ先 投資家向け パートナー向け Oxford Nanopore社で働く 現在の募集状況 営業上の情報 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag